Cardiovasc Intervent Radiol https://doi.org/10.1007/s00270-018-1996-y REVIEW Bariatric Arterial Embolization for Obesity: A Review of Early Clinical Evidence 1,2 3 2 • • Bin-Yan Zhong Godwin Abiola Clifford R. Weiss Received: 5 April 2018 / Accepted: 20 May 2018 Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2018 Abstract Obesity is a worldwide public health epidemic Introduction that leads to increased morbidity, mortality, and cost bur- den to health care. Although bariatric surgery has been Obesity, deﬁned as having a body mass index (BMI) recognized as a standard invasive treatment for obesity, it C 30 kg/m , is one of the most prevalent public health is accompanied by relatively high morbidity and cost issues of the twenty-ﬁrst century . It is now a major burden, as well as limited treatment outcome. Therefore, cause of morbidity and mortality worldwide and has been alternative treatments with lower morbidity and cost for recognized as a risk factor for several diseases, including surgery that target patients who are obese, but not morbidly type 2 diabetes, liver disease, heart disease, degenerative obese, are needed. A minimally invasive trans-catheter joint disease, obstructive sleep apnea, and even malignancy
CardioVascular and Interventional Radiology – Springer Journals
Published: Jun 5, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera